Corvus Pharmaceuticals, Inc. (CRVS) vs Jade Biosciences, Inc. (JBIO)

Corvus Pharmaceuticals, Inc. and Jade Biosciences, Inc. are both Biotechnology companies. Corvus Pharmaceuticals, Inc. and Jade Biosciences, Inc. are of similar size ($992.6M and $936.8M). Across the 9 metrics below, Corvus Pharmaceuticals, Inc. leads on 7 and Jade Biosciences, Inc. on 2.

Valuation

Metric CRVS JBIO Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 4.76 2.00 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (5.25%) (13.31%) (28.84%)
Free cash flow yield (4.21%) (14.06%) (23.03%)

Profitability

Metric CRVS JBIO Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (18.98%) (39.27%) (57.72%)
Return on assets (17.64%) (36.19%) (49.22%)
Return on invested capital (352.49%) 0.00% 0.00%

Growth

Metric CRVS JBIO Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 81.21% 78.57% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRVS JBIO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 16.16 14.93 4.73
Net debt to EBITDA 1.28 2.94 0.96

Dividend

Metric CRVS JBIO Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CRVS JBIO Biotechnology median
Market cap 992.63m 936.79m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack